Life sciences execs turning their backs on social media
5th March 2014
Executives in the pharma and biotech industries have had their fill of social media and are “moving back to an ‘ex-directory’ world, where smaller, restricted networks are of the highest value”.
Writing on the firm’s website, Chris Molloy, chief executive of RSA, the life sciences executive search and interim management firm, argues that “executives have always relied on personal, privileged networks where access is granted with an understanding that it will not be misused”. This group are now “at the forefront of a reaction to the tsunami of random data crashing out of social media channels”.